Arkolith/Insider Trading/RXRX/Form 4

Borgeson Blake

DirectorRECURSION PHARMACEUTICALS, INC. (RXRX) · full profile →Form 4 · filed Jun 4, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$110K
Net Open-Market Flow
-$110K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 2, 2026Sell(S)30K$3.68$110K6.2M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001856094-26-000008) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML